SCHEMBL7169094

SCHEMBL7169094

CCCC(=O)Oc1ccc2c(c1)CC(C)N2C(=O)C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
NOD1 Q9Y239 3/20 0.38
TNF P01375 2/20 0.38
NOD2 Q9HC29 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 2/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814026 0.80 NOD1 (0.41) TP53RAB9ANOD1TNFNOD2
SCHEMBL6813708 0.76 ALDH1A1 (0.34) TP53ALDH1A1RAB9ANPC1KMT2A
SCHEMBL6805435 0.75 TNF (0.53) RAB9ANOD1TNFNOD2LMNA
SCHEMBL6813709 0.68 BCL9 (0.36) ALDH1A1KMT2AGAAMEN1MAPT
SCHEMBL2209599 0.65 LMNA (0.68) ALDH1A1RAB9ANOD1TNFNOD2
SCHEMBL2205547 0.65 LMNA (0.68) ALDH1A1RAB9ANOD1TNFNOD2
SCHEMBL12428954 0.65 LMNA (0.68) ALDH1A1RAB9ANOD1TNFNOD2
SCHEMBL28570413 0.65 HIF1A (0.43) ALDH1A1KMT2AGAAMAPT
SCHEMBL11023644 0.64 BCL9 (0.70) ALDH1A1RAB9AKMT2ASMN1; SMN2LMNA
SCHEMBL28518145 0.64 KMT2A (0.49) TP53ALDH1A1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1334090-A1 NOVEL BICYCLIC ISOXAZOLINONES AS ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-08-13 EP disclosed
WO-2002102785-A1 NOVEL BICYCLIC ISOXAZOLINONES AS ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2002-12-27 WO disclosed